PMC:7029759 / 13525-13730 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"294","span":{"begin":96,"end":105},"obj":"Species"}],"attributes":[{"id":"A294","pred":"tao:has_database_id","subj":"294","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T241","span":{"begin":40,"end":48},"obj":"GO:0042571"},{"id":"T240","span":{"begin":49,"end":55},"obj":"UBERON:0002405;GO:0006955"},{"id":"T239","span":{"begin":56,"end":64},"obj":"GO:0006955"},{"id":"T238","span":{"begin":78,"end":83},"obj":"NCBITaxon:10239"},{"id":"T237","span":{"begin":84,"end":92},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T236","span":{"begin":96,"end":105},"obj":"SP_7"},{"id":"T235","span":{"begin":132,"end":142},"obj":"GO:0042571"},{"id":"T234","span":{"begin":170,"end":175},"obj":"NCBITaxon:10239"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T64","span":{"begin":40,"end":48},"obj":"Body_part"}],"attributes":[{"id":"A64","pred":"fma_id","subj":"T64","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T37","span":{"begin":4,"end":13},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T116","span":{"begin":27,"end":28},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T117","span":{"begin":170,"end":175},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":84,"end":92},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T8","span":{"begin":49,"end":64},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV. Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of inf"}